October 25, 2017 by Chain Drug Review
George Fairweather, Rite Aid, Rite Aid asset sale, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) plans to close 600 stores starting next year as it rationalizes its U.S. drug store base following the $4.375 billion purchase of 1,932 Rite Aid stores. In reporting its fiscal 2017 fourth-quarter and annual results on Wednesday, WBA said it expects to finalize the Rite Aid store acquisition
October 25, 2017 by Chain Drug Review
AllianceRx Walgreens Prime, Rite Aid, Stefano Pessina, Walgreens
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) beat Wall Street’s adjusted earnings per share forecast for its 2017 fourth quarter and fiscal year, with pharmacy results helping boost sales for both periods. However, WBA said Wednesday that costs related to the unsuccessful deal to acquire Rite Aid Corp. impacted its bottom line and pulled down
September 25, 2017 by Bill Schiffner
John Standley, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger
2017, Issue 09-25-2017, Issues, News
DEERFIELD, Ill. — Winding down a nearly two-year process, Walgreens Boots Alliance Inc. (WBA) has gained Federal Trade Commission approval to buy 1,932 stores, three distribution centers and inventory from Rite Aid Corp. for $4.375 billion in cash. The transaction also includes the WBA’s assumption of related real estate leases and an option for Rite
September 19, 2017 by Bill Schiffner
John Standley, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, Walgreens Boots Alliance Development GmbH, Walgreens-Rite Aid merger
Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Winding down a process that has taken nearly two years, Walgreens Boots Alliance Inc. has gained Federal Trade Commission approval to acquire 1,932 stores, three distribution centers and related inventory from Rite Aid Corp. for $4.375 billion in cash. The companies said Tuesday that the transaction also includes the WBA’s assumption of
August 7, 2017 by Greg Jacobson and Chain Drug Review
Fred's, John Standley, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA-Rite Aid deal
2017, Issue 08-07-2017, Issues, News
NEW YORK — With the acquisition of Rite Aid Corp. by Walgreens Boots Alliance Inc. (WBA) now canceled and replaced by a smaller transaction, the chain drug landscape will retain a more familiar look. Nonetheless, all three parties to the original deal, which involved the purchase of 865 Rite Aid locations by Fred’s Inc., will
July 5, 2017 by Chain Drug Review
Brian Tanquilut, Fitch Ratings, Jefferies, Rite Aid, Scot Mushkin, Stefano Pessina, Walgreens Boots Alliance, Wolfe Research
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Analysts said Walgreens Boots Alliance turned in a solid third quarter and stands to emerge on a positive note from its new deal with Rite Aid Corp. upon the termination of their merger. For the third quarter ended May 31, WBA posted net earnings (GAAP) of $1.16 billion, or $1.07 per diluted
June 29, 2017 by Chain Drug Review
Rite Aid, Stefano Pessina, Walgreens Boots Alliance
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — The long, drawn-out quest of Walgreens Boots Alliance Inc. (WBA) to acquire Rite Aid Corp. took another unexpected turn this morning when the two companies announced a new agreement under which WBA will purchase 2,186 stores, three distribution centers and related inventory from Rite Aid. The price will be $5.175 billion in
June 5, 2017 by Geoff Walden and Chain Drug Review
Federal Trade Commission, Fred's, John Standley, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger
2017, Issue 06-05-2017, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) has taken action to force the hand of federal regulators deciding whether to approve its pending acquisition of Rite Aid Corp. WBA and Rite Aid last month notified the Federal Trade Commission that they have complied with the agency’s second request for information on the deal. While
May 9, 2017 by Chain Drug Review
John Standley, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill., and CAMP HILL, Pa. — Walgreens Boots Alliance (WBA) and Rite Aid Corp. said they have met the Federal Trade Commission’s second request for information on their planned merger. Late Monday, WBA and Rite Aid announced that they have “certified substantial compliance,” meaning that they have provided the information needed to determine if
April 22, 2017 by Scot Meyer and Chain Drug Review
Fred's, Mike Bloom, Rite Aid, Stefano Pessina, Walgreens Boots Alliance
2017, Issue 04-24-2017, Issues, News
NEW YORK — Walgreens Boots Alliance Inc. (WBA) executive vice chairman and chief executive officer Stefano Pessina has expressed confidence that the company’s planned merger with Rite Aid Corp. will be approved by the end of July. “I am still optimistic that we will bring this deal to a successful conclusion, but there is no
April 22, 2017 by Greg Jacobson and Chain Drug Review
Alex Gourlay, Beauty Differentiation, George Fairweather, No7, Soap & Glory, Stefano Pessina, Walgreens, Walgreens Boots Alliance
2017, Issue 04-24-2017, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) is reaping success with its beauty differentiation program and is now planning to expand the initiative to more than 1,000 additional Walgreens stores by the end of 2017 while introducing more exclusive brands into the assortment. The first phase of the Walgreens beauty differentiation program’s rollout called
April 5, 2017 by Chain Drug Review
Duane Reade, Stefano Pessina, Walgreens, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Despite an uptick in its Retail Pharmacy USA division, Walgreens Boots Alliance (WBA) reported declined sales for its fiscal 2017 second quarter, with adjusted earnings per share in line with Wall Street’s consensus estimate. Also on Wednesday, WBA had no further news to report on the status of the antitrust review of
March 13, 2017 by Geoff Walden and Chain Drug Review
corporate social responsibility, Get a Shot. Give a Shot, Kevin Walgreen, Ornella Barra, Richard Ellis, Stefano Pessina, UN Foundation, Walgreens Boots Alliance
2017, Issue 03-13-2017, Issues, News
WASHINGTON — There was a time not all that many years ago when corporate social responsibility (CSR) was viewed by most companies as a second- or third-tier priority, something good to do but not a central part of the business model. That thinking has changed radically in recent years, with CSR taking its rightful place
February 27, 2017 by Scot Meyer and Chain Drug Review
Brian Cornell, President Donald Trump, Retail Industry Leaders Association, RILA, Stefano Pessina, Target Corp., Walgreens Boots Alliance
2017, Issue 02-27-2017, Issues, News
WASHINGTON — A group of retail executives, including Walgreens Boots Alliance executive chairman and chief executive officer Stefano Pessina, met with President Donald Trump earlier this month to discuss issues related to imports and changes to the tax code. The meeting was a scheduled event with the Retail Industry Leaders Association (RILA). “The retail industry